FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2004689666> ?p ?o ?g. }

• W2004689666 endingPage "1375" @default.
• W2004689666 startingPage "1367" @default.
• W2004689666 abstract "Treatment with glucocorticoid (GC) is the preferred therapy for polymyalgia rheumatica (PMR), but some patients show poor responses to the initial GC regimen or experience flares on GC tapering. Alternative therapies for patients with GC resistance have not yet been established. To evaluate pretreatment characteristics and therapeutic outcomes of GC-resistant PMR, we followed all patients who had been diagnosed with PMR between October 2007 and February 2013, according to our standardized protocol. GC-resistant patients were defined as those who had responded poorly to the initial GC regimen (15 mg/day of prednisolone) or those who had responded to the initial regimen but had experienced a flare upon GC tapering to 5 mg/day of the maintenance dose or within the first 6 months of maintenance therapy. Out of 23 patients, nine were found to be GC-resistant cases and the others were GC responders. Baseline values of PMR activity score and its components, especially the ability to elevate the upper limbs (EUL), were significantly higher in GC-resistant patients compared with GC responders. The additional use of methotrexate (MTX, five cases), salazosulfapyridine (one case), and tocilizumab (TCZ, three cases) was effective for GC-resistant patients, although 13 to 39 weeks were required for the achievement of remission. We report the three GC-resistant cases in which TCZ was added to GC therapy with or without MTX. We also review the medical literature on the use of TCZ as of January 31, 2014 and discuss the utility of TCZ in the treatment of GC-resistant PMR." @default.
• W2004689666 created "2016-06-24" @default.
• W2004689666 creator A5012013248 @default.
• W2004689666 creator A5041180973 @default.
• W2004689666 date "2014-05-08" @default.
• W2004689666 modified "2023-10-13" @default.
• W2004689666 title "Glucocorticoid-resistant polymyalgia rheumatica: pretreatment characteristics and tocilizumab therapy" @default.
• W2004689666 cites W1971672948 @default.
• W2004689666 cites W1981062313 @default.
• W2004689666 cites W1983403395 @default.
• W2004689666 cites W1989068788 @default.
• W2004689666 cites W1997377429 @default.
• W2004689666 cites W2002426477 @default.
• W2004689666 cites W2008624983 @default.
• W2004689666 cites W2013618355 @default.
• W2004689666 cites W2018881833 @default.
• W2004689666 cites W2020229760 @default.
• W2004689666 cites W2028475036 @default.
• W2004689666 cites W2028534155 @default.
• W2004689666 cites W2034248891 @default.
• W2004689666 cites W2047558890 @default.
• W2004689666 cites W2050116365 @default.
• W2004689666 cites W2051461792 @default.
• W2004689666 cites W2058219630 @default.
• W2004689666 cites W2064030783 @default.
• W2004689666 cites W2065329061 @default.
• W2004689666 cites W2067809930 @default.
• W2004689666 cites W2069886122 @default.
• W2004689666 cites W2076498186 @default.
• W2004689666 cites W2084214906 @default.
• W2004689666 cites W2086598637 @default.
• W2004689666 cites W2089514348 @default.
• W2004689666 cites W2092526835 @default.
• W2004689666 cites W2093556378 @default.
• W2004689666 cites W2093961109 @default.
• W2004689666 cites W2100028348 @default.
• W2004689666 cites W2107640777 @default.
• W2004689666 cites W2111894252 @default.
• W2004689666 cites W2117565385 @default.
• W2004689666 cites W2120197181 @default.
• W2004689666 cites W2128783050 @default.
• W2004689666 cites W2130592851 @default.
• W2004689666 cites W2131718588 @default.
• W2004689666 cites W2147116487 @default.
• W2004689666 cites W2150453553 @default.
• W2004689666 cites W2168309830 @default.
• W2004689666 cites W2168788921 @default.
• W2004689666 cites W2180244775 @default.
• W2004689666 cites W4242842719 @default.
• W2004689666 doi "https://doi.org/10.1007/s10067-014-2650-y" @default.
• W2004689666 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4844628" @default.
• W2004689666 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24803231" @default.
• W2004689666 hasPublicationYear "2014" @default.
• W2004689666 type Work @default.
• W2004689666 sameAs 2004689666 @default.
• W2004689666 citedByCount "37" @default.
• W2004689666 countsByYear W20046896662014 @default.
• W2004689666 countsByYear W20046896662015 @default.
• W2004689666 countsByYear W20046896662016 @default.
• W2004689666 countsByYear W20046896662017 @default.
• W2004689666 countsByYear W20046896662018 @default.
• W2004689666 countsByYear W20046896662019 @default.
• W2004689666 countsByYear W20046896662020 @default.
• W2004689666 countsByYear W20046896662021 @default.
• W2004689666 countsByYear W20046896662022 @default.
• W2004689666 countsByYear W20046896662023 @default.
• W2004689666 crossrefType "journal-article" @default.
• W2004689666 hasAuthorship W2004689666A5012013248 @default.
• W2004689666 hasAuthorship W2004689666A5041180973 @default.
• W2004689666 hasBestOaLocation W20046896661 @default.
• W2004689666 hasConcept C114138010 @default.
• W2004689666 hasConcept C121684516 @default.
• W2004689666 hasConcept C126322002 @default.
• W2004689666 hasConcept C198451711 @default.
• W2004689666 hasConcept C2776015282 @default.
• W2004689666 hasConcept C2776712624 @default.
• W2004689666 hasConcept C2776715498 @default.
• W2004689666 hasConcept C2777178219 @default.
• W2004689666 hasConcept C2777575956 @default.
• W2004689666 hasConcept C2778720950 @default.
• W2004689666 hasConcept C2779134260 @default.
• W2004689666 hasConcept C2780079024 @default.
• W2004689666 hasConcept C2780841215 @default.
• W2004689666 hasConcept C2781059491 @default.
• W2004689666 hasConcept C2781413609 @default.
• W2004689666 hasConcept C41008148 @default.
• W2004689666 hasConcept C71924100 @default.
• W2004689666 hasConcept C90924648 @default.
• W2004689666 hasConceptScore W2004689666C114138010 @default.
• W2004689666 hasConceptScore W2004689666C121684516 @default.
• W2004689666 hasConceptScore W2004689666C126322002 @default.
• W2004689666 hasConceptScore W2004689666C198451711 @default.
• W2004689666 hasConceptScore W2004689666C2776015282 @default.
• W2004689666 hasConceptScore W2004689666C2776712624 @default.
• W2004689666 hasConceptScore W2004689666C2776715498 @default.
• W2004689666 hasConceptScore W2004689666C2777178219 @default.
• W2004689666 hasConceptScore W2004689666C2777575956 @default.
• W2004689666 hasConceptScore W2004689666C2778720950 @default.

• next